The treatment of lung cancer by gene editing technology and its comparison with traditional therapies

Abstract. In the past, drug resistance in the anti-cancer process has been a major factor affecting the treatment of non-small cell lung cancer, which has greatly reduced the quality of life of patients, accompanied by greater suffering and lower survival rates. This article mainly discusses the possibility and practical feasibility of gene editing technology for curing some types of cancer under the current state of technology, and through analysis it finds that gene editing technology can greatly improve the negative effects of traditional drug treatment and chemotherapy, but the relatively immature technology and high cost often discourage many people. There are already experimented ways to cure cancer. For example, CRISPR-Cas9 gene editing technology is currently the easiest, most efficient, and most diverse way to edit genomes, and it is also one of the most attractive applications. It is hoped that it will be promoted and applied in the future while reducing costs.